Trade Mark Journal No.2026/041 9 October 2026

WO0000001939216 (9,42)

Office of origin: European Union Intellectual Property Office (EUIPO)

Date of International Registration:19 August 2026
Date of designation in the UK: 19 August 2026
Image for mark 1939216_TIF IMMUNASIGHT

Class 9
Artificial intelligence software for healthcare; artificial intelligence software; machine learning software for surveillance; machine learning software for healthcare; machine learning software.
Class 42
Design and development of medical diagnostic apparatus; biomedical research services; consultancy in the field of pharmaceutical research; consultancy pertaining to pharmacology; development of gene-based medicines; medical research in the field of oncology; pharmaceutical research services; research and development of pharmaceutical preparations for treating malignant tumours; research and development for the pharmaceutical industry; research and development of vaccines and medicines; research in the field of immunologic tolerance; scientific investigations for medical purposes; analysis in the field of molecular biology; biochemical research and development; consultancy relating to biotechnology; research and development services relating to vaccines; research and development services in the field of immunology.

NEC BIO B.V.

Representative: Luuk van der Laan, Koningin WIlhelminplein 2b, NL-1062 HK Amsterdam, NETHERLANDS